Literature DB >> 17567769

Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.

Monica E Embers1, Mary B Jacobs, Barbara J B Johnson, Mario T Philipp.   

Abstract

Lyme borreliosis (LB) is a disease for which antibody-based detection assays are often required for diagnosis. The variable surface molecule VlsE and IR6, one of its invariable regions, are commonly targeted by the antibody response in infected individuals. A series of enzyme-linked immunosorbent assays was performed to comparatively examine the antibody responses of North American LB patients (n = 37) to VlsE and invariable segments of this molecule. Both immunoglobulin M (IgM) and IgG responses to full-length VlsE and to peptides reproducing invariable regions 2, 4, and 6, as well as the invariable domains at the amino and carboxyl termini of VlsE, were assessed. The proportions and specificities of reactivity to the invariable segments were tested by using cognate peptides as competitors for VlsE binding by patient serum antibodies. IR6 epitopes (by the C6 peptide) were found to dominate the response to invariable segments. IR6 (C6)-specific antibodies were detected in 78% of the serum specimens, whereas <40% of patients generated antibodies that bound the N- or C-terminal domain and <12% of patients responded to either IR2 or IR4. Interestingly, 15 of 37 patients generated IgG antibodies that reacted with C6 but not with VlsE. Conversely, IgM responses were frequent for VlsE but not for invariable segments. A representative number of the serum specimens (n = 8) that contained IgG antibodies reacting with both C6 and VlsE was assessed in competition experiments, using C6 as a competitor. Only half of these specimens contained IgG antibodies whose binding to VlsE could be inhibited >50% by competition with the added C6 peptide. The median percent inhibition was 45.5%. These findings indicate that IR6 epitopes are largely concealed from the VlsE molecular surface and that full-length VlsE-based diagnosis likely detects antibodies to conformational and/or variable region epitopes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567769      PMCID: PMC2044495          DOI: 10.1128/CVI.00075-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  14 in total

1.  Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi.

Authors:  Christoph Eicken; Vivek Sharma; Thomas Klabunde; Matthew B Lawrenz; John M Hardham; Steven J Norris; James C Sacchettini
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

2.  Case definitions for public health surveillance.

Authors:  M Wharton; T L Chorba; R L Vogt; D L Morse; J W Buehler
Journal:  MMWR Recomm Rep       Date:  1990-10-19

3.  Cryptic and exposed invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi sl.

Authors:  F T Liang; J M Nowling; M T Philipp
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

4.  Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes.

Authors:  J R Zhang; J M Hardham; A G Barbour; S J Norris
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes.

Authors:  F T Liang; L C Bowers; M T Philipp
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.

Authors:  F T Liang; A L Alvarez; Y Gu; J M Nowling; R Ramamoorthy; M T Philipp
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

7.  Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi.

Authors:  F T Liang; M T Philipp
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

8.  Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.

Authors:  F T Liang; A C Steere; A R Marques; B J Johnson; J N Miller; M T Philipp
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

9.  Comparison of Western immunoblotting and the C6 Lyme antibody test for laboratory detection of Lyme disease.

Authors:  Elena Mogilyansky; Chien Chang Loa; Martin E Adelson; Eli Mordechai; Richard C Tilton
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

10.  Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi.

Authors:  J R Zhang; S J Norris
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more
  20 in total

1.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

2.  Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.

Authors:  Richard B Porwancher; C Greg Hagerty; Jianqing Fan; Lisa Landsberg; Barbara J B Johnson; Mark Kopnitsky; Allen C Steere; Karen Kulas; Susan J Wong
Journal:  Clin Vaccine Immunol       Date:  2011-03-02

3.  Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.

Authors:  John A Branda; Klemen Strle; Lise E Nigrovic; Paul M Lantos; Timothy J Lepore; Nitin S Damle; Mary Jane Ferraro; Allen C Steere
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

4.  Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.

Authors:  Adoracion Pegalajar-Jurado; Martin E Schriefer; Ryan J Welch; Marc R Couturier; Tiffany MacKenzie; Rebecca J Clark; Laura V Ashton; Mark J Delorey; Claudia R Molins
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

5.  Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease.

Authors:  Peter D Burbelo; Alexandra T Issa; Kathryn H Ching; Jeffrey I Cohen; Michael J Iadarola; Adriana Marques
Journal:  Clin Vaccine Immunol       Date:  2010-04-14

6.  Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

Authors:  Elzbieta Jacek; Kevin S Tang; Lars Komorowski; Mary Ajamian; Christian Probst; Brian Stevenson; Gary P Wormser; Adriana R Marques; Armin Alaedini
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

7.  Dynamic longitudinal antibody responses during Borrelia burgdorferi infection and antibiotic treatment of rhesus macaques.

Authors:  Monica E Embers; Nicole R Hasenkampf; Mary B Jacobs; Mario T Philipp
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

8.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

9.  Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Authors:  Gary P Wormser; Martin Schriefer; Maria E Aguero-Rosenfeld; Andrew Levin; Allen C Steere; Robert B Nadelman; John Nowakowski; Adriana Marques; Barbara J B Johnson; J Stephen Dumler
Journal:  Diagn Microbiol Infect Dis       Date:  2012-10-11       Impact factor: 2.803

10.  Antigenic Variation in Bacterial Pathogens.

Authors:  Guy H Palmer; Troy Bankhead; H Steven Seifert
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.